The frequency of C-KIT mutation was noted to be highest, with 30% (n = 17) of the patients harboring it, followed by AML-1::ETO gene fusion in 28% (n = 16) of patients which results from translocation t (8;21) (q22;q22). This evidence concerns the gene RUNX1T1 and acute myeloid leukemia.